Sugimoto Ken, Ogawa Atsuhiro, Shimomura Yasuyo, Nagahama Kiyotaka, Mizoguchi Atsushi, Bhan Atul K
Department of Pathology, Immunopathology Unit, Massachusetts General Hospital, Boston 02114, USA.
Gastroenterology. 2007 Jul;133(1):124-36. doi: 10.1053/j.gastro.2007.03.112. Epub 2007 Apr 14.
BACKGROUND & AIMS: Our previous studies have identified a B-cell subset that is induced under inflammatory conditions in T-cell receptor alpha knockout (TCRalphaKO) mice and contributes to the attenuation of colitis by producing interleukin (IL)-10. However, it is unclear whether IL-10-producing B cells directly or indirectly regulate inflammation.
Cytokine production of purified mesenteric lymph node (MLN) B cells was examined by flow cytometric analysis, enzyme-linked immunosorbent assay, quantitative polymerase chain reaction, and RNase protection assay. To investigate the functional role of IL-12p70 in the pathogenesis of colitis in TCRalphaKO mice, IL-12p35-deficient TCRalpha double knockout mice were generated.
In the absence of B cells or IL-10, IL-12p35 expression was significantly down-regulated in the MLN of TCRalphaKO mice. The expression of IL-12p35 was restored in the recipient B-cell-deficient TCRalpha double knockout (alphamicroDKO) mice by the transfer of B cells capable of producing IL-10. Notably, B cells predominantly produced IL-12p35 in the MLN through the help of IL-10-producing B cells. Functionally, IL-12 is involved in the regulation of the T-helper (Th) 2-mediated inflammation as indicated by the development of much more severe colitis in IL-12p35-deficient TCRalpha double knockout (alphap35DKO) mice compared with TCRalphaKO mice. In addition, transfer of MLN B cells from TCRalphaKO mice but not from alphap35DKO mice suppressed colitis in recipient alphamicroDKO mice.
These studies have identified a novel IL-12-producing regulatory B-cell subset that develops under Th2-mediated intestinal inflammatory conditions and in the presence of IL-10 and is involved in the regulation of intestinal inflammation.
我们之前的研究在T细胞受体α基因敲除(TCRαKO)小鼠的炎症条件下鉴定出一个B细胞亚群,该亚群通过产生白细胞介素(IL)-10促进结肠炎的缓解。然而,尚不清楚产生IL-10的B细胞是直接还是间接调节炎症。
通过流式细胞术分析、酶联免疫吸附测定、定量聚合酶链反应和核糖核酸酶保护测定来检测纯化的肠系膜淋巴结(MLN)B细胞的细胞因子产生情况。为了研究IL-12p70在TCRαKO小鼠结肠炎发病机制中的作用,构建了IL-12p35缺陷型TCRα双敲除小鼠。
在缺乏B细胞或IL-10的情况下,TCRαKO小鼠MLN中IL-12p35的表达显著下调。通过转移能够产生IL-10的B细胞,受体B细胞缺陷型TCRα双敲除(αmicroDKO)小鼠中IL-12p35的表达得以恢复。值得注意的是,B细胞主要通过产生IL-10的B细胞的辅助在MLN中产生IL-12p35。在功能上,IL-12参与调节T辅助(Th)2介导的炎症,这表现为与TCRαKO小鼠相比,IL-12p35缺陷型TCRα双敲除(αp35DKO)小鼠的结肠炎更为严重。此外,来自TCRαKO小鼠而非αp35DKO小鼠的MLN B细胞转移可抑制受体αmicroDKO小鼠的结肠炎。
这些研究鉴定出一个新的产生IL-12的调节性B细胞亚群,该亚群在Th2介导的肠道炎症条件下且在IL-10存在时发育,并参与肠道炎症的调节。